{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.1/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id": "Sufentanil",
            "Path": "../../Sufentanil.json",
            "BuildingBlocks": []
        }
    ],
    "ObservedDataSets": [],
    "Plots": {
        "PlotSettings": {
            "ChartWidth": 500,
            "ChartHeight": 400,
            "Fonts": {
                "AxisSize": 11,
                "LegendSize": 9,
                "OriginSize": 9,
                "FontFamilyName": "Arial",
                "WatermarkSize": 40
            }
        },
        "AxesSettings": {
            "ComparisonTimeProfile": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "µg/l",
                    "Dimension": "Concentration (mass)",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsPredictedVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "DDIRatioPlotsResidualsVsObserved": [
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "GOFMergedPlotsPredictedVsObserved": [
                {
                    "Unit": "µg/l",
                    "Dimension": "Concentration (mass)",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "µg/l",
                    "Dimension": "Concentration (mass)",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ],
            "GOFMergedPlotsResidualsOverTime": [
                {
                    "Unit": "h",
                    "Dimension": "Time",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Linear"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Linear"
                }
            ],
            "PKRatioPlots": [
                {
                    "Unit": "year(s)",
                    "Dimension": "Age",
                    "Type": "X",
                    "GridLines": false,
                    "Scaling": "Log"
                },
                {
                    "Unit": "",
                    "Dimension": "Dimensionless",
                    "Type": "Y",
                    "GridLines": false,
                    "Scaling": "Log"
                }
            ]
        },
        "AllPlots": [
            {
                "Project": "Sufentanil",
                "Simulation": "Bovill 1984",
                "SectionId": 42
            },
            {
                "Project": "Sufentanil",
                "Simulation": "Willsie 2014 adults IV",
                "SectionId": 42
            },
            {
                "Project": "Sufentanil",
                "Simulation": "Taverne 1992",
                "SectionId": 42
            }
        ],
        "GOFMergedPlots": [
            {
                "Title": "Goodness of fit plor for concentration in plasma.",
                "SectionId": 41,
                "Artifacts": [
                    "Plot",
                    "GMFE",
                    "Measure"
                ],
                "PlotType": "predictedVsObserved|residualsOverTime",
                "Groups": [
                    {
                        "Caption": "Sufentanil iv",
                        "Symbol": "Triangle",
                        "OutputMappings": [
                            {
                                "Project": "Sufentanil",
                                "Simulation": "Bovill 1984",
                                "Output": "Organism|PeripheralVenousBlood|Sufentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Bovill 1984 - mean - Sufentanil - IV - 5 mg/kg - Plasma - agg. (n=10)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Sufentanil",
                                "Simulation": "Willsie 2014 adults IV",
                                "Output": "Organism|PeripheralVenousBlood|Sufentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Willsie 2015 - mean - Sufentanil - IV - 15 µg - Plasma - agg. (n=25)",
                                "Color": "#000000"
                            },
                            {
                                "Project": "Sufentanil",
                                "Simulation": "Taverne 1992",
                                "Output": "Organism|PeripheralVenousBlood|Sufentanil|Plasma (Peripheral Venous Blood)",
                                "ObservedData": "Taverne 1992 - mean - Sufentanil - iv - 150 µg - Plasma - agg. (n=10)",
                                "Color": "#000000"
                            }
                        ]
                    }
                ]
            }
        ],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [
        {
            "Project": "Sufentanil",
            "Name": "Sufentanil",
            "Type": "Compound",
            "SectionId": 40
        }
    ],
    "Sections": [
        {
            "Id": 1,
            "Title": "1 Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "2 Methods",
            "Content": "Content/Section2_Methods.md",
            "Sections": [
                {
                    "Id": 21,
                    "Content": "Content/Section2.1_Modeling_Strategy.md",
                    "Title": "2.1 Modeling strategy"
                },
                {
                    "Id": 22,
                    "Content": "Content/Section2.2_Data_used.md",
                    "Title": "2.2 Data used"
                },
                {
                    "Id": 23,
                    "Content": "Content/Section2.3_Model_Parameters_and_Assumptions.md",
                    "Title": "2.3 Model parameters and assumptions"
                }
            ]
        },
        {
            "Id": 3,
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Title": "3 Results and Discussion",
            "Sections": [
                {
                    "Id": 40,
                    "Content": "Content/Input_table.md",
                    "Title": "3.1 Sufentanil final input parameters"
                },
                {
                    "Id": 41,
                    "Content": "Content/GOF_diagnostics.md",
                    "Title": "3.2 Sufentanil Diagnostics Plots"
                },
                {
                    "Id": 42,
                    "Content": "Content/Concentration_time_profiles.md",
                    "Title": "3.3 Sufentanil Concentration-Time profiles"
                }
            ]
        },
        {
            "Id": 4,
            "Content": "Content/Section4_Conclusion.md",
            "Title": "4 Conclusion"
        },
        {
            "Id": 5,
            "Content": "Content/References.md",
            "Title": "5 References"
        }
    ],
    "Intro": [
        {
            "Path": "Content/titlepage.md"
        }
    ]
}